Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical, Inc. \De\ (LFCR) Return on Assets (2016 - 2025)

Historic Return on Assets for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q1 2025 value amounting to 0.0%.

  • Lifecore Biomedical, Inc. \De\'s Return on Assets changed 0.0% to 0.0% in Q1 2025 from the same period last year, while for Feb 2025 it was 0.0%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.01% for FY2024, which is 1400.0% up from last year.
  • Per Lifecore Biomedical, Inc. \De\'s latest filing, its Return on Assets stood at 0.0% for Q1 2025, which was down 0.0% from 0.0% recorded in Q4 2024.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Return on Assets ranged from a high of 0.01% in Q2 2024 and a low of 0.4% during Q3 2022
  • Moreover, its 5-year median value for Return on Assets was 0.1% (2023), whereas its average is 0.12%.
  • Per our database at Business Quant, Lifecore Biomedical, Inc. \De\'s Return on Assets crashed by -3700bps in 2022 and then skyrocketed by 3300bps in 2024.
  • Lifecore Biomedical, Inc. \De\'s Return on Assets (Quarter) stood at 0.13% in 2021, then plummeted by -93bps to 0.24% in 2022, then surged by 57bps to 0.1% in 2023, then soared by 103bps to 0.0% in 2024, then plummeted by -100bps to 0.0% in 2025.
  • Its Return on Assets stands at 0.0% for Q1 2025, versus 0.0% for Q4 2024 and 0.0% for Q3 2024.